Table 3.

Adverse events (AE) related to anti-tumor necrosis factor treatment. Data are number (%) unless otherwise indicated.

Adverse EventInfliximab, n = 48Adalimumab, n = 43
Major AE00
Minor AE9 (18.7)2 (4.7)
Infections30
  Upper respiratory tract10
  Herpes zoster virus10
  Urinary tract10
Infusion reactions30
Systemic symptoms32
  Headache20
  Irritability10
  Urticarial rash01
  Prolonged menses01